AZD-8075

N/A

Report date: 2022/07/19 16:22:54

NME

Base Information

Drug NameAZD-8075

Drug Alias NameAZD-8075

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProstaglandin D2 receptor antagonists

TargetsProstaglandin D2 receptor

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAstrazeneca Plc

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A